0000950170-24-062585.txt : 20240520 0000950170-24-062585.hdr.sgml : 20240520 20240520183026 ACCESSION NUMBER: 0000950170-24-062585 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240520 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bair Teresa Brophy CENTRAL INDEX KEY: 0001813058 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 24966386 MAIL ADDRESS: STREET 1: C/O KURA ONCOLOGY, INC. STREET 2: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 ownership.xml 4 X0508 4 2024-05-20 0001422143 Kura Oncology, Inc. KURA 0001813058 Bair Teresa Brophy C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 false true false false Chief Legal Officer true Common Stock 2024-05-20 4 S false 2615 22.1477 D 68979 D The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023. 2615 shares were acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. This transaction was executed in multiple trades at prices ranging from $22.06 to $22.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reported sale of 2,615 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023. /s/ Teresa Bair 2024-05-20